申请人:CHEMEX PHARMACEUTICALS, Inc.
公开号:EP0506207A2
公开(公告)日:1992-09-30
This invention relates to the use of a water-soluble zinc-containing compound in a topical pharmaceutical composition containing a pharmacologically active agent to enhance the skin or mucous membrane penetration and retention of the pharmacologically active agent, and to reduce the transdermal flux through the skin and mucous membrane.
本发明涉及在含有药理活性剂的外用药物组合物中使用水溶性含锌化合物,以增强皮肤或粘膜对药理活性剂的渗透和保留,并减少通过皮肤和粘膜的透皮通量。